inflammatory, immune-mediated, and proliferative disorders by targeting distinct kinase enzymes with tailored selectivity. The company combines medicinal chemistry, structure-based design, and translational research to optimize compounds for efficacy, safety, and pharmacokinetic properties that support clinical evaluation. Kinaset Therapeutics collaborates with research institutions and industry partners to advance its programs and validate mechanisms of action in relevant disease models. Its development efforts prioritize therapeutic candidates that may offer differentiated treatment options for conditions driven by dysregulated kinase activity.